ATE537837T1 - Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung - Google Patents
Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündungInfo
- Publication number
- ATE537837T1 ATE537837T1 AT10168703T AT10168703T ATE537837T1 AT E537837 T1 ATE537837 T1 AT E537837T1 AT 10168703 T AT10168703 T AT 10168703T AT 10168703 T AT10168703 T AT 10168703T AT E537837 T1 ATE537837 T1 AT E537837T1
- Authority
- AT
- Austria
- Prior art keywords
- lactic acid
- acid bacteria
- oral inflammation
- reduce bleeding
- bleeding gums
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 4
- 241000894006 Bacteria Species 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000000740 bleeding effect Effects 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 235000014655 lactic acid Nutrition 0.000 title abstract 2
- 239000004310 lactic acid Substances 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 208000007565 gingivitis Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58027904P | 2004-06-14 | 2004-06-14 | |
| US11/147,880 US20050281756A1 (en) | 2004-06-14 | 2005-06-08 | Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE537837T1 true ATE537837T1 (de) | 2012-01-15 |
Family
ID=35480800
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10168703T ATE537837T1 (de) | 2004-06-14 | 2005-06-14 | Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung |
| AT05752662T ATE480248T1 (de) | 2004-06-14 | 2005-06-14 | Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05752662T ATE480248T1 (de) | 2004-06-14 | 2005-06-14 | Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20050281756A1 (e) |
| EP (2) | EP2229949B1 (e) |
| JP (1) | JP2008502714A (e) |
| KR (1) | KR20070018985A (e) |
| CN (2) | CN102851350B (e) |
| AT (2) | ATE537837T1 (e) |
| AU (2) | AU2005251673C1 (e) |
| CA (1) | CA2567867C (e) |
| DE (1) | DE602005023463D1 (e) |
| DK (2) | DK2229949T3 (e) |
| ES (1) | ES2351153T3 (e) |
| IN (1) | IN2006DE07651A (e) |
| NZ (1) | NZ551860A (e) |
| PL (1) | PL1765282T3 (e) |
| PT (1) | PT1765282E (e) |
| SG (1) | SG127405A1 (e) |
| SI (2) | SI2229949T1 (e) |
| WO (1) | WO2005120527A1 (e) |
| ZA (1) | ZA200700211B (e) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1993576T3 (pl) * | 2006-03-07 | 2016-04-29 | Nestec Sa | Mieszanina synbiotyczna |
| CN102115721B (zh) * | 2008-05-08 | 2012-09-26 | 景岳生物科技股份有限公司 | 具有抗炎活性的乳杆菌分离株及其用途 |
| WO2010139690A1 (en) * | 2009-06-03 | 2010-12-09 | Chr. Hansen A/S | Bacteria thya(-) mutants with increased vitamin k |
| US20110014324A1 (en) * | 2009-07-10 | 2011-01-20 | Christoffer Lundqvist | Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution |
| JP5645192B2 (ja) | 2009-07-16 | 2014-12-24 | 国立大学法人広島大学 | 口腔内疾患の予防、改善又は治療剤 |
| US20110293710A1 (en) * | 2010-02-02 | 2011-12-01 | Delphine Saulnier | Immunomodulatory properties of lactobacillus strains |
| US20130022586A1 (en) * | 2011-07-21 | 2013-01-24 | James Versalovic | Production and use of bacterial histamine |
| DE102011116325B4 (de) * | 2011-10-14 | 2016-03-10 | orochemie GmbH + Co. KG | Neue Milchsäurebakterien und diese enthaltende Zusammensetzungen |
| CA2858974A1 (en) * | 2011-12-28 | 2013-07-04 | Amgen Inc. | Method of treating alveolar bone loss through the use of anti-sclerostin antibodies |
| RU2492851C1 (ru) * | 2012-08-02 | 2013-09-20 | Сергей Владимирович Кузнецов | Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции |
| NZ744342A (en) * | 2016-01-19 | 2022-11-25 | Symrise Ag | Probiotics for use as anti-inflammatory agents in the oral cavity |
| US20170273334A1 (en) * | 2016-03-25 | 2017-09-28 | Zoe Kapp | Method of Naturally Decomposing Chewing Gum |
| EP3351259A1 (en) | 2017-01-18 | 2018-07-25 | Symrise AG | Probiotics for aggregation with disease-associated species in the oral cavity |
| US12246078B2 (en) | 2017-09-14 | 2025-03-11 | Gerald P. Curatola | Oral care formulations and methods for use |
| WO2020001747A1 (en) | 2018-06-26 | 2020-01-02 | Symrise Ag | Lactobacillus plantarum for skin care |
| KR102720199B1 (ko) | 2022-06-30 | 2024-10-22 | 대한제당 주식회사 | 우수한 프로폴리스 내성을 가진 신규 구강 유산균 락토바실러스 루테리 tsb-r7 |
| CN118217218A (zh) * | 2024-04-01 | 2024-06-21 | 天津大学 | 预防和治疗牙周炎的益生菌牙膏及其制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1514469A (en) * | 1974-08-01 | 1978-06-14 | Beecham Group Ltd | Oral hygiene compositions |
| US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| US5458875A (en) | 1990-06-15 | 1995-10-17 | Biogaia Ab | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry |
| US5534253A (en) | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| DE69627994D1 (de) * | 1995-12-21 | 2003-06-12 | Biogaia Ab Stockholm | Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren |
| US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| US5800813A (en) * | 1996-11-12 | 1998-09-01 | Biogaia Biologics Ab | Treatment of cryptosporidium infections |
| KR19990024297A (ko) * | 1997-08-07 | 1999-04-06 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| KR100266752B1 (ko) * | 1997-08-07 | 2001-03-02 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| US20030077814A1 (en) * | 1997-08-07 | 2003-04-24 | Oh Jong Suk | Novel lactic acid bacteria |
| US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| US6080401A (en) * | 1998-11-19 | 2000-06-27 | Reddy; Malireddy S. | Herbal and pharmaceutical drugs enhanced with probiotics |
| ATE419331T1 (de) * | 2000-08-25 | 2009-01-15 | Wakamoto Pharma Co Ltd | L. salivarius-stamm enthaltende probiotische produkte |
| KR100843020B1 (ko) * | 2002-03-29 | 2008-07-01 | 가부시키가이샤 프렌테 인터내셔날 | 유산균을 유효성분으로 하는 생균제제 및 유산균 함유 식품 |
| JP2003299480A (ja) * | 2002-04-09 | 2003-10-21 | Hiroki Futagawa | 虫歯予防用細菌、虫歯予防用食品、虫歯予防用口腔洗浄剤及びヨーグルトの製造方法 |
| US7105336B2 (en) | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| CN1216145C (zh) * | 2002-11-07 | 2005-08-24 | 上海新立工业微生物科技有限公司 | 一种嗜热乳酸杆菌以及采用该菌种生产l－乳酸的方法 |
| US6872565B2 (en) * | 2003-01-29 | 2005-03-29 | Biogaia Ab | Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries |
-
2005
- 2005-06-08 US US11/147,880 patent/US20050281756A1/en not_active Abandoned
- 2005-06-14 DE DE602005023463T patent/DE602005023463D1/de not_active Expired - Lifetime
- 2005-06-14 EP EP10168703A patent/EP2229949B1/en not_active Expired - Lifetime
- 2005-06-14 SI SI200531484T patent/SI2229949T1/sl unknown
- 2005-06-14 AU AU2005251673A patent/AU2005251673C1/en not_active Expired
- 2005-06-14 CA CA2567867A patent/CA2567867C/en not_active Expired - Fee Related
- 2005-06-14 JP JP2007527137A patent/JP2008502714A/ja active Pending
- 2005-06-14 KR KR1020067025745A patent/KR20070018985A/ko not_active Ceased
- 2005-06-14 CN CN201210342792.1A patent/CN102851350B/zh not_active Expired - Lifetime
- 2005-06-14 CN CN2005800192621A patent/CN1980683B/zh not_active Expired - Lifetime
- 2005-06-14 SG SG200607929A patent/SG127405A1/en unknown
- 2005-06-14 PT PT05752662T patent/PT1765282E/pt unknown
- 2005-06-14 WO PCT/SE2005/000897 patent/WO2005120527A1/en active Application Filing
- 2005-06-14 NZ NZ551860A patent/NZ551860A/en not_active IP Right Cessation
- 2005-06-14 AT AT10168703T patent/ATE537837T1/de active
- 2005-06-14 PL PL05752662T patent/PL1765282T3/pl unknown
- 2005-06-14 EP EP05752662A patent/EP1765282B1/en not_active Expired - Lifetime
- 2005-06-14 SI SI200531151T patent/SI1765282T1/sl unknown
- 2005-06-14 ZA ZA200700211A patent/ZA200700211B/en unknown
- 2005-06-14 AT AT05752662T patent/ATE480248T1/de active
- 2005-06-14 DK DK10168703.6T patent/DK2229949T3/da active
- 2005-06-14 ES ES05752662T patent/ES2351153T3/es not_active Expired - Lifetime
- 2005-06-14 DK DK05752662.6T patent/DK1765282T3/da active
-
2006
- 2006-12-18 IN IN7651DE2006 patent/IN2006DE07651A/en unknown
-
2009
- 2009-04-02 US US12/384,327 patent/US20090238774A1/en not_active Abandoned
-
2010
- 2010-05-06 AU AU2010201837A patent/AU2010201837A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2006DE07651A (e) | ||
| DE60325379D1 (de) | Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen | |
| WO2009144458A3 (en) | Food product | |
| DE60216614D1 (de) | Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln | |
| ATE444746T1 (de) | Eine herstellungsmethode von entacapon- enthaltenden granulaten für orale dosierformen | |
| MY148096A (en) | 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments | |
| BR112012015750A2 (pt) | composição para higiene oral, método para melhorar o cumprimento de um plano de tratamento pelo paciente com uma composição para higiene oral, e, método para branqueamento de uma superfície dental | |
| CY1113177T1 (el) | Φαινυλαμινο-βενζοξαζολ-υποκατεστημενα καρβοξυλικα οξεα, μεθοδος για την παρασκευη τους και η χρηση τους ως φαρμακων | |
| EA200800451A1 (ru) | Лечение дигидропиридиновыми блокаторами кальциевых каналов и жирными кислотами омега-3 и их комбинированным продуктом | |
| CY1110812T1 (el) | Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| DE50212760D1 (de) | Ermittlung des patientenbezogenen Kariesrisikos | |
| UY27841A1 (es) | Amidas de ácidos 2-heteroarilcarboxílicos | |
| ATE402924T1 (de) | Pyridiniumsalze und deren verwendung | |
| MY150686A (en) | Oral composition containing morin | |
| ATE464045T1 (de) | Zusammensetzung aus milchsäure und lactoferrin | |
| MY162652A (en) | Novel use of quinolone antibiotics | |
| CY1110458T1 (el) | Παραγωγα βενγαμιδης και η χρηση τους στην αγωγη καρκινικων παθησεων | |
| DE602005019703D1 (de) | Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin | |
| ATE455789T1 (de) | Substituierte nonadepsipeptide | |
| BR112015023496A2 (pt) | Métodos para promover higiene oral | |
| ATE361085T1 (de) | Verwendung einer zusätzlich fermentierten getreideschlempe zur vorbeugung und/oder behandlung erhähter blutzucker-werte | |
| ITMI20051991A1 (it) | Purificazione di prodotti beta-lattamici | |
| WO2008121006A8 (en) | Selenium administration | |
| ATE427111T1 (de) | Vorbeugung von zahnerosion durch die verwendung von colostrumprotein |